The Cholestatic Pruritus Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Cholestatic Pruritus Market?
The market size of the cholestatic pruritus has seen significant growth lately. The market cap that was $19.20 billion in 2024 will increase to $20.28 billion in 2025, representing a compound annual growth rate (CAGR) of 5.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Cholestatic Pruritus Industry?
The Cholestatic Pruritus Global Market is projected to grow to $24.97 billion in 2029, with a compound annual growth rate (CAGR) of 5.3%.
Download Your Free Sample of the 2025 Cholestatic Pruritus Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Cholestatic Pruritus Market?
The key drivers in the cholestatic pruritus market are:
• Growth in the elderly population
• Increasing incidence of atopic dermatitis and urticaria
• Rise in chronic kidney diseases
• Growing occurrence of conditions connected with pruritus
Global Market Segmentation: Identifying Major Cholestatic Pruritus Industry Segments
The cholestatic pruritus market covered in this report is segmented –
1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types
2) By Treatment Type: Medications, Phototherapy, Other Treatment Types
3) By Route Of Administration: Oral, Topical, Injectable
4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare
Subsegments:
1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure
2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures
3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk
4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders
Pre-order the 2025 Cholestatic Pruritus Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Cholestatic Pruritus Market?
The key trends in the cholestatic pruritus market are:
• Introduction of new treatment methodologies is an emerging trend.
• There is a rising trend of partnerships with major players for cholestasis pruritus research.
• Innovation in treatment modalities is significantly influencing the market trends.
• The expansion of healthcare facilities and technological innovation are notable market trends.
Who Are the Top Competitors & Leading Players in the Cholestatic Pruritus Market?
Major players in the cholestatic pruritus market are:
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Merck KGaA
• Regeneron Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Incyte Corporation
• Ipsen Pharma
• Vanda Pharmaceuticals Inc.
• Medison Pharma Ltd.
• Mirum Pharmaceuticals Inc.
• Albireo Pharma Inc.
• Dipharma Francis S.r.l.
• Cara Therapeutics Inc.
• CANbridge Pharmaceuticals Inc.
• Escient Pharmaceuticals Inc.
• Tharimmune Inc.
• Vifor Fresenius Medical Care Renal Pharma
• CymaBay Therapeutics Inc.
• ICE Pharma Inc.
• Aquatic Remedies Private Limited
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the cholestatic pruritus market in 2024
